CXCR4 and Glioblastoma

E-ISSN： 1875-5992|16|1|59-74

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.1, 2016-01, pp. : 59-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigation of CXCR4 in squamous cell carcinoma of the tongue

By Delilbasi C.B. Okura M. Iida S. Kogo M.

Oral Oncology, Vol. 40, Iss. 2, 2004-02 ,pp. : 154-157

Elsevier

Access to resources Recommend Favorite

CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 3, 2012-09 ,pp. : 251-264

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

By Sun Xueqing

Cancer and Metastasis Reviews, Vol. 29, Iss. 4, 2010-12 ,pp. : 709-722

Springer Publishing Company

Access to resources Recommend Favorite

Expression of SDF1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1618-1624

Spandidos Publications

Access to resources Recommend Favorite

Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma

By Rahman Maryam Azari Hassan Deleyrolle Loic Millette Sebastien Zeng Huadong Reynolds Brent A

Future Oncology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1389-1396

Future Medicine

Access to resources Recommend Favorite